Advertisement

Topics

Pyxis Discovery B.V. Company Profile

00:40 EST 22nd November 2017 | BioPortfolio

The ambition of Pyxis Discovery is to be the preferred chemistry service provider for companies that are active in small molecule drug discovery. Pyxis Discovery's Smart approach of designing and selecting compound libraries facilitates a rapid and efficient lead discovery process, yielding lead compounds with excellent pharmacological profiles. Pyxis Discovery uses proprietary software algorithms for compound design and selection and a Global Supplier Database of nearly all commercially available screening compounds to provide its clients with screening libraries that are tailored to their specific needs. Furthermore, Pyxis Discovery offers high quality compound libraries off the shelf. Pyxis Discovery is headquartered in the Netherlands and has a worldwide presence with also an office in Boston, Massachusetts and representation in Japan.


News Articles [230 Associated News Articles listed on BioPortfolio]

Thun Hospital use BD's Pyxis MedStation™ system to automate medication management

BD (Becton, Dickinson and Company), a leading global medical technology company, today announced the STS AG Hospital in Thun, Switzerland has become the first hospital in the world to introduce a full...

Sygnature Discovery partners on pancreatic cancer research

Sygnature Discovery, which claims to be the UK’s largest independent drug discovery expert and research…

BRIEF—UK’s Medicines Discovery Catapult in new AMR project

The Medicines Discovery Catapult, the UK government-backed body that seeks to speed drug discovery and…

Target class drug discovery

Selection of molecular targets based on disease understanding is a dominant paradigm in drug discovery. We argue that a focus on classes of targets with central roles in biology provides a complimenta...

The Current issue of “The view from here” is concerned with nanoscience in drug discovery.

The topic of this month’s newsletter from Drug Discovery Today is “nanoscience in drug discovery”

Pharmacophore modeling and applications in drug discovery: challenges and recent advances

The most downloaded article from Drug Discovery Today in Q2 2010 was by Sheng-Yong Yang and deals with the application of pharmacophore modeling to drug discovery.

InterMed Discovery: The World's Largest Natural Product Library

In this interview Fintan Walton talks to Mr Erik Metz, Head of Business Development at InterMed Discovery - a Natural Product lead discovery company from Dortmund, Germany. Erik Metz explains how Inte...

Unique collaboration opportunities available for UK SMEs working on drug discovery

Medicines Discovery Catapult, a new national centre established to support innovative drug discovery, is inviting UK SMEs working in medicines to collaborate on high-resolution analysis.

PubMed Articles [563 Associated PubMed Articles listed on BioPortfolio]

Protac-induced Protein Degradation in Drug Discovery: Breaking the Rules - or Just Making New Ones?

Targeted protein degradation, using bifunctional small molecules (Protacs) to remove specific proteins from within cells, has emerged as a novel drug discovery strategy with the potential to offer the...

The Utility of Target-Based Discovery.

18F-FDG silicon photomultiplier PET/CT: A pilot study comparing semi-quantitative measurements with standard PET/CT.

To evaluate if the new Discovery Molecular Insights (DMI) PET/CT scanner provides equivalent results compared to the standard of care PET/CT scanners (GE Discovery 600 or GE Discovery 690) used in our...

Three-Dimensional Cell Culture: A Rapidly Emerging Approach to Cellular Science and Drug Discovery.

From machine learning to deep learning: progress in machine intelligence for rational drug discovery.

Machine intelligence, which is normally presented as artificial intelligence, refers to the intelligence exhibited by computers. In the history of rational drug discovery, various machine intelligence...

Clinical Trials [147 Associated Clinical Trials listed on BioPortfolio]

Discovery Elbow Multi-Center Prospective Study

The purpose of this prospective clinical trial is to document the performance and clinical outcomes of Biomet Discovery Elbow.

A Clinical Investigation of the Discovery™ Elbow System

The purpose of this study is to perform a five-year, multi-center prospective evaluation of the Discovery™ Elbow System for outcome and durability. Relief of pain and restoration of fun...

Endometriosis Biomarker Discovery Study

This is a prospective, Single time point, discovery study intending to identify biomarkers that can differentiate endometriosis from other underlying reasons for pelvic pain. Patients unde...

Protein Biomarker Discovery and Validation in Chronic Obstructive Pulmonary Disease (COPD) And Asthma

The purpose of the study is to better understand the function of asthma and COPD, and response to therapy. There are two Phases to this study broken into two arms. In Phase I, our propose ...

Biologic Basis of Liver Cancer From Chronic Hepatitis B

The focus of the study is to identify viral factors and host immune responses that differentiate HBV-related HCC patients from HBV patients who have not progressed to HCC. To that end, the...

Companies [1069 Associated Companies listed on BioPortfolio]

Pyxis Discovery B.V.

The ambition of Pyxis Discovery is to be the preferred chemistry service provider for companies that are active in small molecule drug discovery. Pyxis Discovery's Smart approach of designing and ...

Pyxis Discovery

Pyxis Discovery offers chemistry-based drug discovery services to the global pharmaceutical industry and develops products and services on the basis of computational chemistry. The activities of Pyxis...

Cardinal Health

Cardinal Health, we understand health care and its unique challenges. When health care leaders called for a better way to safely dispense medications, we were the first to answer with the revolutionar...

Discovery Health

Discovery Health Media includes the Discovery Health and FitTV television networks and online assets, including www.discoveryhealth.com, as well as its Continuing Medical Education (CME) business and ...

Sprout Group

Founded in 1969, the Sprout Group raised its first venture fund of $12 million more than 30 years ago. Since then, Sprout has financed more than 350 companies whose combined revenues now exceed $50 bi...

More Information about "Pyxis Discovery B.V." on BioPortfolio

We have published hundreds of Pyxis Discovery B.V. news stories on BioPortfolio along with dozens of Pyxis Discovery B.V. Clinical Trials and PubMed Articles about Pyxis Discovery B.V. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Pyxis Discovery B.V. Companies in our database. You can also find out about relevant Pyxis Discovery B.V. Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...


Corporate Database Quicklinks



Searches Linking to this Company Record